Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

J. Biol. Chem. 279 (22): 23214-23222

© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.

Differential Desensitization, Receptor Phosphorylation, {beta}-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7*

Trudy A. Kohout{ddagger}§, Shelby L. Nicholas{ddagger}, Stephen J. Perry¶, Greg Reinhart{ddagger}, Sachiko Junger¶, , and R. Scott Struthers{ddagger}

Departments of {ddagger}Exploratory Discovery and Molecular Biology, Neurocrine Biosciences Inc., San Diego, California 92121

Abstract: Many members of the chemokine receptor family of G protein-coupled receptors utilize multiple endogenous ligands. However, differences between the signaling properties of multiple chemokines through a single receptor have yet to be well characterized. In this study we investigated the early signaling events of CCR7 initiated by its two endogenous ligands, CCL19 and CCL21. Both CCL19 and CCL21 induce G protein activation and calcium mobilization with equal potency. However, only activation by CCL19, not CCL21, promotes robust desensitization of endogenous CCR7 in the human T cell lymphoma cell line H9. Desensitization occurs through the induction of receptor phosphorylation and {beta}-arrestin recruitment (shown in HEK293 cells expressing CCR7-FLAG). The sites of CCL19-induced phosphorylation were mapped by mutating to alanines the serines and threonines found within kinase phosphorylation consensus sequences in the carboxyl terminus of CCR7. A cluster of sites, including Thr-373-376 and Ser-378 is important for CCL19-mediated phosphorylation of the receptor, whereas residues serine 356, 357, 364, and 365 are important for basal receptor phosphorylation by protein kinase C. Activation of CCR7 by both ligands leads to signaling to the ERK1/2 mitogen-activated protein kinase pathway. However, CCL19 promotes 4-fold more ERK1/2 phosphorylation than does CCL21. The mechanism by which CCL19 activates ERK1/2 was determined to be {beta}-arrestin-dependent, because it is reduced both by depletion of {beta}-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor. Taken together, these findings demonstrate that CCL19 and CCL21 place CCR7 in functionally distinct conformations that are independent of their G protein-coupling potency: one that allows the efficient desensitization of the receptor and activation of ERK1/2, and another that is impaired in these functions.

Received for publication February 26, 2004. Revision received March 29, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Exploratory Discovery, Neurocrine Biosciences Inc., 10555 Science Center Dr., San Diego, CA 92121. Tel.: 858-320-7538; Fax: 858-658-7602; E-mail: tkohout{at}

CCL-21 Conditioned Regulatory T Cells Induce Allotolerance through Enhanced Homing to Lymphoid Tissue.
S. K. Chauhan, D. R. Saban, T. H. Dohlman, and R. Dana (2014)
J. Immunol. 192, 817-823
   Abstract »    Full Text »    PDF »
Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors.
S. Rajagopal, D. L. Bassoni, J. J. Campbell, N. P. Gerard, C. Gerard, and T. S. Wehrman (2013)
J. Biol. Chem. 288, 35039-35048
   Abstract »    Full Text »    PDF »
Screening {beta}-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein-Coupled Receptors.
C. Southern, J. M. Cook, Z. Neetoo-Isseljee, D. L. Taylor, C. A. Kettleborough, A. Merritt, D. L. Bassoni, W. J. Raab, E. Quinn, T. S. Wehrman, et al. (2013)
J Biomol Screen 18, 599-609
   Abstract »    Full Text »    PDF »
{beta}-Arrestin-2 Desensitizes the Transient Receptor Potential Vanilloid 1 (TRPV1) Channel.
E. D. Por, S. M. Bierbower, K. A. Berg, R. Gomez, A. N. Akopian, W. C. Wetsel, and N. A. Jeske (2012)
J. Biol. Chem. 287, 37552-37563
   Abstract »    Full Text »    PDF »
Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration.
K. Schaeuble, M. A. Hauser, A. V. Rippl, R. Bruderer, C. Otero, M. Groettrup, and D. F. Legler (2012)
J. Cell Sci. 125, 4463-4474
   Abstract »    Full Text »    PDF »
Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues.
F. Hoffmann, W. Muller, D. Schutz, M. E. Penfold, Y. H. Wong, S. Schulz, and R. Stumm (2012)
J. Biol. Chem. 287, 28362-28377
   Abstract »    Full Text »    PDF »
CCR7/CCL19 Controls Expression of EDG-1 in T Cells.
L. A. Shannon, T. M. McBurney, M. A. Wells, M. E. Roth, P. A. Calloway, C. A. Bill, S. Islam, and C. M. Vines (2012)
J. Biol. Chem. 287, 11656-11664
   Abstract »    Full Text »    PDF »
Signaling through L-Selectin Mediates Enhanced Chemotaxis of Lymphocyte Subsets to Secondary Lymphoid Tissue Chemokine.
H. Subramanian, J. J. Grailer, K. C. Ohlrich, A. L. Rymaszewski, J. J. Loppnow, M. Kodera, R. M. Conway, and D. A. Steeber (2012)
J. Immunol. 188, 3223-3236
   Abstract »    Full Text »    PDF »
Distinct Phosphorylation Sites on the {beta}2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of {beta}-Arrestin.
K. N. Nobles, K. Xiao, S. Ahn, A. K. Shukla, C. M. Lam, S. Rajagopal, R. T. Strachan, T.-Y. Huang, E. A. Bressler, M. R. Hara, et al. (2011)
Science Signaling 4, ra51
   Abstract »    Full Text »    PDF »
Biased Ligands for Better Cardiovascular Drugs: Dissecting G-Protein-Coupled Receptor Pharmacology.
S. M. DeWire and J. D. Violin (2011)
Circ. Res. 109, 205-216
   Abstract »    Full Text »    PDF »
Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
U. Haessler, M. Pisano, M. Wu, and M. A. Swartz (2011)
PNAS 108, 5614-5619
   Abstract »    Full Text »    PDF »
Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on {beta}-Arrestin Recruitment, Gαi Signaling, and Receptor Internalization.
Y. A. Berchiche, S. Gravel, M.-E. Pelletier, G. St-Onge, and N. Heveker (2011)
Mol. Pharmacol. 79, 488-498
   Abstract »    Full Text »    PDF »
{beta}-Arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration.
C. A. Grotegut, L. Feng, L. Mao, R. P. Heine, A. P. Murtha, and H. A. Rockman (2011)
Am J Physiol Endocrinol Metab 300, E468-E477
   Abstract »    Full Text »    PDF »
Dendritic Cells Distinguish Individual Chemokine Signals through CCR7 and CXCR4.
B. G. Ricart, B. John, D. Lee, C. A. Hunter, and D. A. Hammer (2011)
J. Immunol. 186, 53-61
   Abstract »    Full Text »    PDF »
Differential Signaling of the Endogenous Agonists at the {beta}2-Adrenergic Receptor.
S. Reiner, M. Ambrosio, C. Hoffmann, and M. J. Lohse (2010)
J. Biol. Chem. 285, 36188-36198
   Abstract »    Full Text »    PDF »
Dopamine D1-D2 Receptor Heteromer-mediated Calcium Release Is Desensitized by D1 Receptor Occupancy with or without Signal Activation: DUAL FUNCTIONAL REGULATION BY G PROTEIN-COUPLED RECEPTOR KINASE 2.
V. Verma, A. Hasbi, B. F. O'Dowd, and S. R. George (2010)
J. Biol. Chem. 285, 35092-35103
   Abstract »    Full Text »    PDF »
PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.
R. Muthuswamy, J. Mueller-Berghaus, U. Haberkorn, T. A. Reinhart, D. Schadendorf, and P. Kalinski (2010)
Blood 116, 1454-1459
   Abstract »    Full Text »    PDF »
Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21.
A. Rey-Gallardo, C. Escribano, C. Delgado-Martin, J. L. Rodriguez-Fernandez, R. Gerardy-Schahn, U. Rutishauser, A. L. Corbi, and M. A. Vega (2010)
Glycobiology 20, 1139-1146
   Abstract »    Full Text »    PDF »
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery.
T. Kenakin and L. J. Miller (2010)
Pharmacol. Rev. 62, 265-304
   Abstract »    Full Text »    PDF »
CCR7 Deficiency Leads to Leukocyte Activation and Increased Clearance in Response to Pulmonary Pseudomonas aeruginosa Infection.
B. L. Eppert, G. T. Motz, B. W. Wortham, J. L. Flury, and M. T. Borchers (2010)
Infect. Immun. 78, 2099-2107
   Abstract »    Full Text »    PDF »
Regulation of G Protein-Coupled Receptor Signaling: Specific Dominant-Negative Effects of Melanocortin 2 Receptor Accessory Protein 2.
J. A. Sebag and P. M. Hinkle (2010)
Science Signaling 3, ra28
   Abstract »    Full Text »    PDF »
Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders.
L. Wang, B. Martin, R. Brenneman, L. M. Luttrell, and S. Maudsley (2009)
J. Pharmacol. Exp. Ther. 331, 340-348
   Abstract »    Full Text »    PDF »
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands.
D. A. Zidar, J. D. Violin, E. J. Whalen, and R. J. Lefkowitz (2009)
PNAS 106, 9649-9654
   Abstract »    Full Text »    PDF »
Kappa Opioid Receptor Screen with the TangoTM {beta}-Arrestin Recruitment Technology and Characterization of Hits with Second-Messenger Assays.
C. Doucette, K. Vedvik, E. Koepnick, A. Bergsma, B. Thomson, and T. C. Turek-Etienne (2009)
J Biomol Screen 14, 381-394
   Abstract »    PDF »
CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface.
L. Achour, M. G. H. Scott, H. Shirvani, A. Thuret, G. Bismuth, C. Labbe-Jullie, and S. Marullo (2009)
Blood 113, 1938-1947
   Abstract »    Full Text »    PDF »
Dynamic Modulation of CCR7 Expression and Function on Naive T Lymphocytes In Vivo.
M. R. Britschgi, A. Link, T. K. A. Lissandrin, and S. A. Luther (2008)
J. Immunol. 181, 7681-7688
   Abstract »    Full Text »    PDF »
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21.
M. A. Byers, P. A. Calloway, L. Shannon, H. D. Cunningham, S. Smith, F. Li, B. C. Fassold, and C. M. Vines (2008)
J. Immunol. 181, 4723-4732
   Abstract »    Full Text »    PDF »
Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis.
C. Otero, P. S. Eisele, K. Schaeuble, M. Groettrup, and D. F. Legler (2008)
J. Cell Sci. 121, 2759-2767
   Abstract »    Full Text »    PDF »
Agonist-selective signaling is determined by the receptor location within the membrane domains.
H. Zheng, J. Chu, Y. Qiu, H. H. Loh, and P.-Y. Law (2008)
PNAS 105, 9421-9426
   Abstract »    Full Text »    PDF »
Additive Roles for MCP-1 and MCP-3 in CCR2-Mediated Recruitment of Inflammatory Monocytes during Listeria monocytogenes Infection.
T. Jia, N. V. Serbina, K. Brandl, M. X. Zhong, I. M. Leiner, I. F. Charo, and E. G. Pamer (2008)
J. Immunol. 180, 6846-6853
   Abstract »    Full Text »    PDF »
Multiple Roles for the C-terminal Tail of the Chemokine Scavenger D6.
C. V. McCulloch, V. Morrow, S. Milasta, I. Comerford, G. Milligan, G. J. Graham, N. W. Isaacs, and R. J. B. Nibbs (2008)
J. Biol. Chem. 283, 7972-7982
   Abstract »    Full Text »    PDF »
{beta}-Arrestins: Multifunctional Cellular Mediators.
L. Barki-Harrington and H. A. Rockman (2008)
Physiology 23, 17-22
   Abstract »    Full Text »    PDF »
-Arrestin-Dependent {micro}-Opioid Receptor-Activated Extracellular Signal-Regulated Kinases (ERKs) Translocate to Nucleus in Contrast to G Protein-Dependent ERK Activation.
H. Zheng, H. H. Loh, and P.-Y. Law (2008)
Mol. Pharmacol. 73, 178-190
   Abstract »    Full Text »    PDF »
Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections.
H. Unsoeld, K. Mueller, U. Schleicher, C. Bogdan, J. Zwirner, D. Voehringer, and H. Pircher (2007)
Int. Immunol. 19, 1281-1289
   Abstract »    Full Text »    PDF »
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21.
E. M. Pierce, K. Carpenter, C. Jakubzick, S. L. Kunkel, H. Evanoff, K. R. Flaherty, F. J. Martinez, G. B. Toews, and C. M. Hogaboam (2007)
Eur. Respir. J. 29, 1082-1093
   Abstract »    Full Text »    PDF »
Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice.
B. Xu, K. Aoyama, M. Kusumoto, A. Matsuzawa, E. C. Butcher, S. A. Michie, T. Matsuyama, and T. Takeuchi (2007)
Int. Immunol. 19, 775-784
   Abstract »    Full Text »    PDF »
An Opioid Agonist that Does Not Induce {micro}-Opioid Receptor--Arrestin Interactions or Receptor Internalization.
C. E. Groer, K. Tidgewell, R. A. Moyer, W. W. Harding, R. B. Rothman, T. E. Prisinzano, and L. M. Bohn (2007)
Mol. Pharmacol. 71, 549-557
   Abstract »    Full Text »    PDF »
GRKs and arrestins: regulators of migration and inflammation.
A. Vroon, C. J. Heijnen, and A. Kavelaars (2006)
J. Leukoc. Biol. 80, 1214-1221
   Abstract »    Full Text »    PDF »
Arrestin Is Required for Agonist-induced Trafficking of Voltage-dependent Calcium Channels.
A. Puckerin, L. Liu, N. Permaul, P. Carman, J. Lee, and M. A. Diverse-Pierluissi (2006)
J. Biol. Chem. 281, 31131-31141
   Abstract »    Full Text »    PDF »
Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation.
C. Otero, M. Groettrup, and D. F. Legler (2006)
J. Immunol. 177, 2314-2323
   Abstract »    Full Text »    PDF »
The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells.
N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez (2006)
J. Immunol. 176, 5153-5159
   Abstract »    Full Text »    PDF »
Seven-Transmembrane Receptor Signaling Through {beta}-Arrestin.
S. K. Shenoy and R. J. Lefkowitz (2005)
Sci. STKE 2005, cm10
   Abstract »    Full Text »    PDF »
Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help.
S. Hardtke, L. Ohl, and R. Forster (2005)
Blood 106, 1924-1931
   Abstract »    Full Text »    PDF »
The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling.
S. Maudsley, B. Martin, and L. M. Luttrell (2005)
J. Pharmacol. Exp. Ther. 314, 485-494
   Abstract »    Full Text »    PDF »
CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.
P. C. Fulkerson, H. Zhu, D. A. Williams, N. Zimmermann, and M. E. Rothenberg (2005)
Blood 106, 436-443
   Abstract »    Full Text »    PDF »
Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis.
B. Lagane, S. Ballet, T. Planchenault, K. Balabanian, E. Le Poul, C. Blanpain, Y. Percherancier, I. Staropoli, G. Vassart, M. Oppermann, et al. (2005)
Mol. Pharmacol. 67, 1966-1976
   Abstract »    Full Text »    PDF »
Transduction of Receptor Signals by {beta}-Arrestins.
R. J. Lefkowitz and S. K. Shenoy (2005)
Science 308, 512-517
   Abstract »    Full Text »    PDF »
Distinct Conformations of the Corticotropin Releasing Factor Type 1 Receptor Adopted following Agonist and Antagonist Binding Are Differentially Regulated.
S. J. Perry, S. Junger, T. A. Kohout, S. R. J. Hoare, R. S. Struthers, D. E. Grigoriadis, and R. A. Maki (2005)
J. Biol. Chem. 280, 11560-11568
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882